ArticleOncogene2020
Targeting the IL-1β/EHD1/TUBB3 axis overcomes resistance to EGFR-TKI in NSCLC.
Jian Huang et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
37 papers cite it
this paperpooled itcites it
ArticleOncogene2020
Jian Huang et al.PubMed ↗Publisher ↗
No numbers read from the abstract.